RE:Slides to today’s conference… So their product is Zanidatamab for GastroIntestinal Cancer, the clinical trials look good. Now they are setting up a full scale trial in 300 sites over 38 countries - looking for approval within 2, 3, 5 years if the study verifies the clinical trial results. - Could be a blockbuster., possibly one of the pharmacutical giants might buy it up as soon as they see the study is launched? Anyhow - thanks for the slices - seems to be a mass of potential here.